Patents by Inventor Robert E. Pyke

Robert E. Pyke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment regimens
    Patent number: 9517254
    Abstract: The invention further relates to compounds, pharmaceutical compositions and methods for treating all disorders of human sexual function including hypoactive sexual desire disorder (HSDD) in a subject.
    Type: Grant
    Filed: August 6, 2013
    Date of Patent: December 13, 2016
    Assignee: S1 BIOPHARMA, INC.
    Inventors: Nicolas G. Sitchon, Robert E. Pyke, John F. Kaufmann
  • Use of Flibanserin for the Treatment of Post-Menopausal Sexual Desire Disorders
    Publication number: 20150374683
    Abstract: The invention relates to the use of flibanserin for the preparation of a medicament for the treatment of post-menopausal Sexual Desire Disorders.
    Type: Application
    Filed: May 1, 2015
    Publication date: December 31, 2015
    Inventors: Stephane Pollentier, Robert E. Pyke
  • Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
    Publication number: 20150366862
    Abstract: The invention relates to the use of flibanserin for the preparation of a medicament for the treatment of pre-menopausal Sexual Desire Disorders.
    Type: Application
    Filed: March 23, 2015
    Publication date: December 24, 2015
    Inventors: Stephane Pollentier, Robert E. Pyke
  • Pharmaceutical Compositions for the Treatment of Sexual Disorders II
    Publication number: 20150320739
    Abstract: The invention relates to new pharmaceutical compositions for the treatment of sexual disorders and methods for the preparation thereof. In a preferred embodiment, the instant invention is directed to pharmaceutical combinations comprising flibanserin as one active ingredient in combination with at least one additional active ingredient for the treatment of sexual disorders and methods for the preparation thereof.
    Type: Application
    Filed: March 13, 2015
    Publication date: November 12, 2015
    Inventors: Klaus Mendla, Thomas Friedl, Wolfram Eisenreich, Robert E. Pyke
  • TREATMENT REGIMENS
    Publication number: 20150150946
    Abstract: The invention further relates to compounds, pharmaceutical compositions and methods for treating all disorders of human sexual function including hypoactive sexual desire disorder (HSDD) in a subject.
    Type: Application
    Filed: August 6, 2013
    Publication date: June 4, 2015
    Inventors: Nicolas G. Sitchon, Robert E. Pyke, John F. Kaufmann
  • Use of Flibanserin for the Treatment of Post-Menopausal Sexual Desire Disorders
    Publication number: 20150051221
    Abstract: The invention relates to the use of flibanserin for the preparation of a medicament for the treatment of post-menopausal Sexual Desire Disorders.
    Type: Application
    Filed: June 24, 2014
    Publication date: February 19, 2015
    Inventors: Stephane Pollentier, Robert E. Pyke
  • Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
    Publication number: 20140329827
    Abstract: The invention relates to the use of flibanserin for the preparation of a medicament for the treatment of pre-menopausal Sexual Desire Disorders.
    Type: Application
    Filed: March 4, 2014
    Publication date: November 6, 2014
    Applicant: Sprout Pharmaceuticals, Inc.
    Inventors: Stephane Pollentier, Robert E. Pyke
  • Use of flibanserin for the treatment of post-menopausal Sexual Desire Disorders
    Publication number: 20070265276
    Abstract: The invention relates to the use of flibanserin for the preparation of a medicament for the treatment of post-menopausal Sexual Desire Disorders.
    Type: Application
    Filed: May 8, 2007
    Publication date: November 15, 2007
    Inventors: Stephane POLLENTIER, Robert E. PYKE
  • Use of certain 1-substituted-triazolo-benzodiazepines to treat psychoses
    Patent number: 4472397
    Abstract: Certain 1-(Nitrogen-containing group)-triazolo-benzodiazepines, e.g., adinazolam, are useful for treating psychotic, including schizophrenic, conditions in human patients.
    Type: Grant
    Filed: February 18, 1983
    Date of Patent: September 18, 1984
    Assignee: The Upjohn Company
    Inventors: Robert Lahti, Robert E. Pyke